Tortoise Investment Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Tortoise Investment Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-300	Closed	-$13K	–	571
2017 Q4	$13K	Hold	300	–	–	﹤0.01%	364
2017 Q3	$13K	Hold	300	–	–	﹤0.01%	340
2017 Q2	$13K	Hold	300	–	–	﹤0.01%	330
2017 Q1	$13K	Hold	300	–	–	﹤0.01%	309
2016 Q4	$12K	Hold	300	–	–	﹤0.01%	318
2016 Q3	$13K	Hold	300	–	–	﹤0.01%	283
2016 Q2	$13K	Hold	300	–	–	﹤0.01%	285
2016 Q1	$12K	Hold	300	–	–	﹤0.01%	273
2015 Q4	$15K	Hold	300	–	–	0.01%	283
2015 Q3	$14K	Hold	300	–	–	0.01%	275
2015 Q2	$19K	Buy	+300	New	+$18.7K	0.01%	275

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return

Tortoise Investment Management's XPH Position: Q1 2018 in Review

Tortoise Investment Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2018, closing a stake of 300 shares — an estimated $13K sold.

Tortoise Investment Management first reported a position in XPH in Q2 2015 and held it in 11 quarters. The position peaked at $19K in Q2 2015. 75 funds tracked by Wall St. Rank hold XPH as of Q1 2018.

Tortoise Investment Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
Tortoise Investment Management sold 300 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2018, an estimated $13K.
Tortoise Investment Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2015 and held it in 11 quarters.
Tortoise Investment Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $19K in Q2 2015.
75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2018.

Based on Tortoise Investment Management's 13F filing for Q1 2018, filed 11 May 2018.